Cytosorbents Corporation

NASDAQ:CTSO

0.8932 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 36.34929.3640.10939.45322.76620.25213.3828.2064.0563.1450.8220.1520.036000000.01
Cost of Revenue 13.95713.95611.04811.0537.3647.4895.5183.9542.2132.1341.9120.3190.012000000.01
Gross Profit 22.39215.40429.06128.415.40212.7637.8634.2521.8431.011-1.09-0.1680.024000000
Gross Profit Ratio 0.6160.5250.7250.720.6770.630.5880.5180.4540.321-1.326-1.1070.674000000
Reseach & Development Expenses 15.72915.11916.3818.8112.0927.7234.0494.7833.8712.4321.7392.5322.8881.7571.9621.9831.4161.1130
General & Administrative Expenses 37.87237.13638.48231.51224.46822.87615.42612.2838.0126.8363.4851.9821.5731.0670.7570.9091.6510.9390.07
Selling & Marketing Expenses 0.2530.5820.6150.2850.3140000000000.3080.35100.9120
SG&A 36.93637.13638.48231.51224.46822.87615.42612.2838.0126.8363.4851.9821.5731.0671.0651.2611.6511.8520.07
Other Expenses 0.936-5.329-3.057-1.552-2.184-2.252-1.769-1.322-0.736-2.428-1.601-1.1910000000.01
Operating Expenses 53.60146.92651.80638.7734.37628.34817.70615.74411.1478.293.6233.3234.4612.8243.0273.2443.0672.9640.08
Operating Income -31.209-31.522-22.745-10.37-18.974-15.585-9.843-11.492-9.304-7.279-4.713-3.491-4.437-2.824-2.43-3.244-3.067-2.964-0.08
Operating Income Ratio -0.859-1.074-0.567-0.263-0.833-0.77-0.736-1.4-2.294-2.314-5.735-23.031-122.97700000-8
Total Other Income Expenses Net 1.888-2.383-2.551.406-1.384-2.2460.705-0.590.847-2.814-0.423-0.564-1.0455.73312.142-0.022-0.284-4.7070
Income Before Tax -29.321-33.905-25.295-8.964-20.358-17.831-9.138-12.257-8.456-9.707-5.136-4.055-5.4822.9093.036-3.266-3.351-7.672-0.08
Income Before Tax Ratio -0.807-1.155-0.631-0.227-0.894-0.88-0.683-1.494-2.085-3.086-6.25-26.754-151.93900000-8
Income Tax Expense -0.814-1.092-0.736-1.127-1.092-0.62-0.677-0.319-0.325-0.386-0.458-0.3921.0455.8180.299-0.2493.3517.6720
Net Income -28.507-32.813-24.559-7.837-19.266-17.211-8.461-11.939-8.132-9.321-4.678-3.664-5.482-2.909-2.737-3.018-3.351-7.672-0.08
Net Income Ratio -0.784-1.118-0.612-0.199-0.846-0.85-0.632-1.455-2.005-2.964-5.692-24.17-151.93900000-8
EPS -0.64-0.75-0.57-0.2-0.6-0.56-0.31-0.47-0.33-0.65-0.5-0.46-0.86-0.74-1.64-3-3.37-12.82-0.26
EPS Diluted -0.64-0.75-0.57-0.2-0.6-0.56-0.31-0.47-0.33-0.65-0.5-0.46-0.86-0.74-1.64-3-3.37-12.82-0.26
EBITDA -28.811-30.003-22.013-9.71-18.743-15.979-8.17-11.864-9.191-6.827-4.649-3.436-4.396-2.805-2.976-3.141-3.16-1.74-0.07
EBITDA Ratio -0.793-0.99-0.503-0.263-0.833-0.75-0.828-1.316-2.473-2.314-5.657-22.67-121.89200000-7